Type I Interferon Production Induced by RIG-I-Like Receptors
- 1 December 2010
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 30 (12), 875-881
- https://doi.org/10.1089/jir.2010.0117
Abstract
Type I interferon (IFN) is produced in a variety of tissues in the body in response to viral infections. Recent studies have revealed that cytoplasmic receptors for viral (nonself) RNA are responsible for triggering IFN production. Different viruses activate different sensors. Numerous signaling adaptors are reported to participate in the regulation of the IFN gene's activation. In this paper, the role of free polyubiquitine chains in the activation of retinoic acid inducible gene I (RIG-I)-like receptors and the involvement of mitochondria as a signaling platform in the modulation of RIG-I-like receptor signaling is reviewed.Keywords
This publication has 68 references indexed in Scilit:
- Mitochondrial dynamics regulate the RIG‐I‐like receptor antiviral pathwayEMBO Reports, 2009
- RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I PathwayCell, 2009
- RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediateNature Immunology, 2009
- The C-Terminal Regulatory Domain Is the RNA 5′-Triphosphate Sensor of RIG-IMolecular Cell, 2008
- RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATPNature, 2006
- Does Toll-like receptor 3 play a biological role in virus infections?Virology, 2004
- Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNAScience, 2004
- Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic developmentThe Journal of cell biology, 2003
- Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3Nature, 2001
- Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extractsCell, 1978